BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36533670)

  • 1. Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.
    Cholujova D; Beke G; Hunter ZR; Hideshima T; Flores L; Zeleznikova T; Harrachova D; Klucar L; Leiba M; Drgona L; Treon SP; Kastritis E; Dorfman DM; Anderson KC; Jakubikova J
    Int J Cancer; 2023 May; 152(9):1947-1963. PubMed ID: 36533670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
    Jalali S; Ansell SM
    Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the bone marrow in Waldenstrom macroglobulinemia.
    Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa GC; Leleu X; Roccaro AM
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S65-9. PubMed ID: 22035751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
    Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
    Sun H; Fang T; Wang T; Yu Z; Gong L; Wei X; Wang H; He Y; Liu L; Yan Y; Sui W; Xu Y; Yi S; Qiu L; Hao M
    J Transl Med; 2022 Dec; 20(1):576. PubMed ID: 36494694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.
    Kaushal A; Nooka AK; Carr AR; Pendleton KE; Barwick BG; Manalo J; McCachren SS; Gupta VA; Joseph NS; Hofmeister CC; Kaufman JL; Heffner LT; Ansell SM; Boise LH; Lonial S; Dhodapkar KM; Dhodapkar MV
    Blood Cancer Discov; 2021 Nov; 2(6):600-615. PubMed ID: 34778800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia.
    Jalali S; Price-Troska T; Paludo J; Villasboas J; Kim HJ; Yang ZZ; Novak AJ; Ansell SM
    Blood Adv; 2018 Aug; 2(15):1985-1997. PubMed ID: 30104397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.
    Boutilier AJ; Huang L; Elsawa SF
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
    Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia.
    Hodge LS; Ziesmer SC; Yang ZZ; Secreto FJ; Gertz MA; Novak AJ; Ansell SM
    Blood; 2012 Nov; 120(18):3774-82. PubMed ID: 22976953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
    Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
    Jalali S; Ansell SM
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy.
    Barakat FH; Medeiros LJ; Wei EX; Konoplev S; Lin P; Jorgensen JL
    Am J Clin Pathol; 2011 Mar; 135(3):365-73. PubMed ID: 21350089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibrutinib for the treatment of Waldenström macroglobulinemia.
    Chakraborty R; Kapoor P; Ansell SM; Gertz MA
    Expert Rev Hematol; 2015 Oct; 8(5):569-79. PubMed ID: 26138997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
    Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
    Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone marrow microenvironment in Waldenström macroglobulinemia.
    Agarwal A; Ghobrial IM
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):218-21. PubMed ID: 23490994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular origin and malignant transformation of Waldenström macroglobulinemia.
    Paiva B; Corchete LA; Vidriales MB; García-Sanz R; Perez JJ; Aires-Mejia I; Sanchez ML; Barcena P; Alignani D; Jimenez C; Sarasquete ME; Mateos MV; Ocio EM; Puig N; Escalante F; Hernández J; Cuello R; García de Coca A; Sierra M; Montes MC; González-López TJ; Galende J; Bárez A; Alonso J; Pardal E; Orfao A; Gutierrez NC; San Miguel JF
    Blood; 2015 Apr; 125(15):2370-80. PubMed ID: 25655603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.
    Shrimpton J; Care MA; Carmichael J; Walker K; Evans P; Evans C; de Tute R; Owen R; Tooze RM; Doody GM
    Blood Adv; 2020 Jun; 4(12):2821-2836. PubMed ID: 32574366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.
    Kapoor P; Paludo J; Ansell SM
    Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Case of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma with Light Chain Discrepancy between B Lymphocyte Population and Serum Paraprotein.
    Kim HJ; Hur M; Kim H; Moon HW; Yun YM; Kim SY; Lee MH
    Ann Clin Lab Sci; 2015; 45(5):593-7. PubMed ID: 26586715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.